1. Home
  2. TECH vs BEN Comparison

TECH vs BEN Comparison

Compare TECH & BEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • BEN
  • Stock Information
  • Founded
  • TECH 1976
  • BEN 1947
  • Country
  • TECH United States
  • BEN United States
  • Employees
  • TECH N/A
  • BEN N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • BEN Investment Managers
  • Sector
  • TECH Health Care
  • BEN Finance
  • Exchange
  • TECH Nasdaq
  • BEN Nasdaq
  • Market Cap
  • TECH 11.3B
  • BEN 10.7B
  • IPO Year
  • TECH 1989
  • BEN N/A
  • Fundamental
  • Price
  • TECH $73.17
  • BEN $20.50
  • Analyst Decision
  • TECH Buy
  • BEN Sell
  • Analyst Count
  • TECH 8
  • BEN 13
  • Target Price
  • TECH $82.00
  • BEN $22.25
  • AVG Volume (30 Days)
  • TECH 795.5K
  • BEN 4.3M
  • Earning Date
  • TECH 01-30-2025
  • BEN 01-27-2025
  • Dividend Yield
  • TECH 0.44%
  • BEN 6.25%
  • EPS Growth
  • TECH N/A
  • BEN N/A
  • EPS
  • TECH 0.95
  • BEN 0.85
  • Revenue
  • TECH $1,171,583,000.00
  • BEN $8,478,000,000.00
  • Revenue This Year
  • TECH $7.67
  • BEN N/A
  • Revenue Next Year
  • TECH $9.38
  • BEN $3.67
  • P/E Ratio
  • TECH $77.07
  • BEN $24.15
  • Revenue Growth
  • TECH 2.41
  • BEN 8.01
  • 52 Week Low
  • TECH $61.16
  • BEN $18.95
  • 52 Week High
  • TECH $85.57
  • BEN $30.32
  • Technical
  • Relative Strength Index (RSI)
  • TECH 46.90
  • BEN 37.78
  • Support Level
  • TECH $69.48
  • BEN $21.86
  • Resistance Level
  • TECH $77.62
  • BEN $22.82
  • Average True Range (ATR)
  • TECH 2.45
  • BEN 0.67
  • MACD
  • TECH -0.45
  • BEN -0.30
  • Stochastic Oscillator
  • TECH 41.28
  • BEN 16.67

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About BEN Franklin Resources Inc.

Franklin Resources provides investment services for individual and institutional investors. At the end of August 2024, Franklin had $1.681 trillion in managed assets, composed primarily of equity (36%), fixed-income (34%), multi-asset/balanced (10%) funds, alternatives (15%) and money market funds (5%). Distribution tends to be weighted equally between retail investors (52% of AUM) and institutional accounts (46%), with high-net-worth clients accounting for the remainder. Franklin is one of the more global of the US-based asset managers we cover, with 30% of its assets under management invested in global/international strategies and just as much sourced from clients domiciled outside the United States.

Share on Social Networks: